There are a wide-range of medications that have ototoxic effects, and the list is growing with the introduction of new chemotherapeutic agents. It is important to recognize this condition early in order to offer early therapeutic intervention. Monitoring of ototoxic effects requires multi-disciplinary coordination and appropriate baseline and post-therapeutic audiologic monitoring. The goals of this program will be to review many of the ototoxic medications and discuss the components necessary for establishing an ototoxicity monitoring protocol (OMP). In addition, we will review various therapeutic options. We aim to raise awareness about this significant issue and offer insights as to how to manage a complex clinical problem.
- Provider:American Academy of Otolaryngology – Head & Neck Surgery Foundation
- Activity Link: https://academyu.entnet.org/diweb/catalog/item?id=10927584
- Start Date: 2022-10-12 05:00:00
- End Date: 2022-10-12 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABOHNS - 1.0 Point; Credit Type(s): Self-Assessment (ABOHNS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Community/Population Health, Learner Competence, Learner Knowledge, Learner Performance, Patient Health
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Otolaryngology